Literature DB >> 26514174

Radioimmunotherapy: From Current Clinical Success to Future Industrial Breakthrough?

Françoise Kraeber-Bodéré1, Jacques Barbet2, Jean-François Chatal3.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26514174     DOI: 10.2967/jnumed.115.167247

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  4 in total

Review 1.  Current outlook on radionuclide delivery systems: from design consideration to translation into clinics.

Authors:  Oleksii O Peltek; Albert R Muslimov; Mikhail V Zyuzin; Alexander S Timin
Journal:  J Nanobiotechnology       Date:  2019-08-21       Impact factor: 10.435

Review 2.  Combination Radioimmunotherapy Strategies for Solid Tumors.

Authors:  Javeria Zaheer; Hyeongi Kim; Yong-Jin Lee; Jin Su Kim; Sang Moo Lim
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

3.  Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.

Authors:  Aurélie Rondon; Sébastien Schmitt; Arnaud Briat; Nancy Ty; Lydia Maigne; Mercedes Quintana; Rosemery Membreno; Brian M Zeglis; Isabelle Navarro-Teulon; Jean-Pierre Pouget; Jean-Michel Chezal; Elisabeth Miot-Noirault; Emmanuel Moreau; Françoise Degoul
Journal:  Theranostics       Date:  2019-09-19       Impact factor: 11.556

Review 4.  Radiolabeled Antibodies for Cancer Imaging and Therapy.

Authors:  Sagun Parakh; Sze Ting Lee; Hui K Gan; Andrew M Scott
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.